Masimo Corporation (MASI): Price and Financial Metrics


Masimo Corporation (MASI): $175.83

1.11 (+0.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MASI POWR Grades

  • MASI scores best on the Sentiment dimension, with a Sentiment rank ahead of 96.67% of US stocks.
  • The strongest trend for MASI is in Sentiment, which has been heading up over the past 178 days.
  • MASI's current lowest rank is in the Momentum metric (where it is better than 18.65% of US stocks).

MASI Stock Summary

  • MASI's current price/earnings ratio is 62.95, which is higher than 91.67% of US stocks with positive earnings.
  • The price/operating cash flow metric for MASIMO CORP is higher than 98.8% of stocks in our set with a positive cash flow.
  • Revenue growth over the past 12 months for MASIMO CORP comes in at 64.29%, a number that bests 88.26% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to MASIMO CORP, a group of peers worth examining would be LOGI, QGEN, ITT, APDN, and DCBO.
  • Visit MASI's SEC page to see the company's official filings. To visit the company's web site, go to www.masimo.com.

MASI Valuation Summary

  • In comparison to the median Healthcare stock, MASI's price/sales ratio is 131.58% higher, now standing at 4.4.
  • MASI's price/sales ratio has moved down 0.2 over the prior 190 months.

Below are key valuation metrics over time for MASI.

Stock Date P/S P/B P/E EV/EBIT
MASI 2023-03-17 4.4 6.7 62.9 50.5
MASI 2023-03-16 4.5 6.9 64.2 51.5
MASI 2023-03-15 4.5 6.8 63.5 50.9
MASI 2023-03-14 4.6 7.0 65.6 52.5
MASI 2023-03-13 4.5 6.9 64.4 51.6
MASI 2023-03-10 4.5 6.8 63.4 50.8

MASI Growth Metrics

    Its 2 year revenue growth rate is now at 27.52%.
  • Its 4 year revenue growth rate is now at 37.48%.
  • Its 4 year net cashflow from operations growth rate is now at -46.42%.
Over the past 34 months, MASI's revenue has gone up $1,060,002,000.

The table below shows MASI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 2,035.8 29.4 143.5
2022-09-30 1,746.419 133.603 170.853
2022-06-30 1,504.533 205.096 190.724
2022-03-31 1,244.351 228.652 222.859
2021-12-31 1,239.153 264.754 229.647
2021-09-30 1,206.629 231.569 232.058

MASI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MASI has a Quality Grade of B, ranking ahead of 88.45% of graded US stocks.
  • MASI's asset turnover comes in at 0.714 -- ranking 51st of 186 Medical Equipment stocks.
  • BLFS, NVNO, and ZYXI are the stocks whose asset turnover ratios are most correlated with MASI.

The table below shows MASI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-02 0.714 0.647 0.384
2021-07-03 0.702 0.642 0.380
2021-04-03 0.705 0.643 0.387
2021-01-02 0.700 0.650 0.408
2020-09-26 0.705 0.660 0.413
2020-06-27 0.720 0.669 0.414

MASI Price Target

For more insight on analysts targets of MASI, see our MASI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $298.80 Average Broker Recommendation 1.56 (Moderate Buy)

MASI Stock Price Chart Interactive Chart >

Price chart for MASI

MASI Price/Volume Stats

Current price $175.83 52-week high $184.96
Prev. close $174.72 52-week low $108.89
Day low $175.30 Volume 86,489
Day high $176.94 Avg. volume 362,358
50-day MA $168.96 Dividend yield N/A
200-day MA $148.04 Market Cap 9.25B

Masimo Corporation (MASI) Company Bio


Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies worldwide. The Company's core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The company was founded in 1989 and is based in Irvine, California.


MASI Latest News Stream


Event/Time News Detail
Loading, please wait...

MASI Latest Social Stream


Loading social stream, please wait...

View Full MASI Social Stream

Latest MASI News From Around the Web

Below are the latest news stories about MASIMO CORP that investors may wish to consider to help them evaluate MASI as an investment opportunity.

Masimo (MASI) PVi Achieves Acceptable Fluid Response in Study

Masimo (MASI) PVi helps clinicians reliably predict fluid responsiveness in young neurosurgical patients.

Yahoo | March 16, 2023

European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring

NEUCHATEL, Switzerland, March 15, 2023--Updated ESAIC guidelines recommend noninvasive, continuous hemoglobin monitoring to help clinicians manage perioperative bleeding.

Yahoo | March 15, 2023

New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery

NEUCHATEL, Switzerland, March 09, 2023--A new study found that Masimo PVi® performed reliably as a predictor of fluid responsiveness in young children undergoing neurosurgery.

Yahoo | March 9, 2023

Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives

IRVINE, Calif. & PHILADELPHIA, March 07, 2023--Masimo and Temple Health are entering into a strategic innovation collaboration focused on hospital automation and telehealth.

Yahoo | March 7, 2023

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients

NEUCHATEL, Switzerland, March 06, 2023--A study has found that noninvasive Masimo PVi® was as effective in guiding fluid management in adult neurosurgical patients as invasive SVV.

Yahoo | March 6, 2023

Read More 'MASI' Stories Here

MASI Price Returns

1-mo 6.73%
3-mo 19.75%
6-mo 23.46%
1-year 11.19%
3-year 13.37%
5-year 105.24%
YTD 18.84%
2022 -49.47%
2021 9.09%
2020 69.80%
2019 47.21%
2018 26.62%

Continue Researching MASI

Want to see what other sources are saying about Masimo Corp's financials and stock price? Try the links below:

Masimo Corp (MASI) Stock Price | Nasdaq
Masimo Corp (MASI) Stock Quote, History and News - Yahoo Finance
Masimo Corp (MASI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9822 seconds.